While still much less is known about the molecular actions of ERK3 signaling in cancers in comparison with the well‐studied ERK1/2 signaling, recent years have seen a considerable gain of our understanding of the roles of ERK3 in cancer development. The gene discussed is MAPK6; the disease is cancer.